ClinicalTrials.Veeva

Menu

Closed Loop Ventilation Strategy in Intensive Care Unit (ICU) Patients

I

Izmir Dr Suat Seren Chest Diseases and Surgery Education and Research Hospital

Status and phase

Completed
Phase 4

Conditions

Respiratory Failure
All Intubated Patients

Treatments

Device: Adaptive Support Ventilation
Device: Pressure Controlled Ventilation

Study type

Interventional

Funder types

Other

Identifiers

NCT01472302
IGCEAH-ICU 2

Details and patient eligibility

About

Adaptive support ventilation (ASV) is a closed loop ventilation mode that can act both like PCV and PSV automatically. Some studies suggest that ASV can reduce the weaning time in ICU patients. The investigators hypothesized that using ASV from the beginning of intubation can reduce the total duration of MV and LOS in the ICU when compared to conventional modes such as PCV+PSV

Enrollment

229 patients

Sex

All

Ages

19+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Intubated and mechanically ventilated ICU patients for more than 24 hours

Exclusion criteria

  • Patient with a tracheostomy
  • Patients under home mechanical ventilation

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

229 participants in 2 patient groups

ASV
Experimental group
Description:
Adaptive Support Ventilation
Treatment:
Device: Adaptive Support Ventilation
PCV
Active Comparator group
Description:
Pressure Controlled Ventilation
Treatment:
Device: Pressure Controlled Ventilation

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems